Tag Cardiovascular health

News

GLP-1 Drugs Like Ozempic and Wegovy May Shield Autoimmune Disease Patients From Deadly Heart Events

GLP-1 injection pen used for weight loss and diabetes treatment, representing research on autoimmune disease and heart health.

People living with both obesity and an autoimmune disease already face a complicated health picture. New research suggests that GLP-1 receptor agonist medications may offer these patients real protection against serious cardiovascular complications. The study was published June 7, 2026,…

Adeeba
June 8, 2026

GLP-1 Medications, Guides, Obesity Conditions

Beyond Weight Loss: How GLP-1 Medications Protect the Heart

Person using an injection pen to administer a GLP-1 weight-loss medication into abdominal fat.

GLP-1 receptor agonists initially entered clinical practice primarily for glycemic control. Accumulating cardiovascular outcome trial data have subsequently revealed a broader pharmacological profile. These medications now hold a significant position within endocrinology and cardiology. Given this, their clinical implications extend…

Adeeba
March 11, 2026